Coppell Advisory Solutions’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$447K Buy
+15,537
New +$382K 0.05% 224

Other funds holding ADPT

Coppell Advisory Solutions's ADPT Position: Q3 2026 in Review

Coppell Advisory Solutions opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2026: 15,537 shares worth $447K. The stake represents 0.05% of the portfolio and ranks #224 among its holdings.

334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Coppell Advisory Solutions held 15,537 shares of Adaptive Biotechnologies worth $447K as of Q3 2026.
  • Adaptive Biotechnologies was a new Coppell Advisory Solutions position in Q3 2026.
  • Adaptive Biotechnologies made up 0.05% of Coppell Advisory Solutions's portfolio in Q3 2026, its #224 holding.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Coppell Advisory Solutions's 13F filing for Q3 2026, filed 16 Nov 2026.